Citigroup Maintains Buy on Cardinal Health, Lowers Price Target to $245

Benzinga Newsdesk www.benzinga.com Negative 56.1%

Neg 56.1% Neu 0% Pos 0%

Citigroup analyst Daniel Grosslight maintains Cardinal Health (NYSE:CAH) with a Buy and lowers the price target from $249 to $245.